Daily non-political popular news in brief.
Statin use associated with lower risk of death and hospitalization for patients with heart failure
10-31-2006 · EurekAlert!Patients with heart failure who used statins for the first time had a reduced risk of death of nearly 25 percent, compared to non-users, and also a lower risk for hospitalization, according to a study in the Nov. 1 issue of JAMA.
Read more »
Keywords: statin, associated, lower, risk, death, hospitalization, patients, heart, failure, patient
« Previous | Next »
Similar news on "Statin use associated with lower risk of death and hospitalization for patients with heart failure":
- Novel candidate biomarker for heart failure also strongly predicts risk of death
08-06-2007 · EurekAlert!
A potential new biomarker for heart failure may be more powerful than established measures in identifying patients at increased risk for death from several causes. In their report, an international research team describes finding that blood levels of a protein called ST2 both indicate the presence of heart failure among patient with shortness of breath and powerfully predict the risk that a patient will die during the following year.
Similar news · Read more »
- Due to cost, heart attack patients often avoid follow-up care and medication
03-13-2007 · EurekAlert!
A lack of funds to pay for medical treatment and prescriptions is common among heart attack patients and leads to a worse recovery, more angina, poorer quality of life and higher risk of re-hospitalization, according to a study by researchers at Yale School of Medicine. Published in the March 14 issue of Journal of the American Medical Association (JAMA), the study sought to determine if self-reported financial barriers to health care services or medication were associated with worse patient outcomes.
Similar news · Read more »
- MU researchers find statin drugs also may help reduce risk of heart failure, sudden cardiac death
05-01-2007 · EurekAlert!
Statin drugs, known primarily for their ability to lower cholesterol, also may reduce the overactive sympathetic nervous system response that contributes to the worsening of heart failure and increases the risk of sudden cardiac death, two University of Missouri-Columbia researchers have found. Heart failure is the leading cause of morbidity and mortality in the United States.
Similar news · Read more »
- Hospitalized heart failure patients may benefit from oral tolvaptan
03-25-2007 · EurekAlert!
A diagnosis of worsening acute decompensated heart failure (ADHF) is characterized by the development of dyspnea (shortness of breath) associated with the rapid accumulation of fluid in the lungs. Patients who are hospitalized with ADFA need rapid and sustained fluid retention without risking renal dysfunction. Tolvaptan has been shown to achieve rapid and sustained results in this patient population, according to a study presented today at the American College of Cardiology’s 56th Annual Scientific Session.
Similar news · Read more »
- Certain infusion therapy after heart attack does not appear to be beneficial, may cause harm
11-27-2007 · EurekAlert!
Infusion of a combination therapy consisting of glucose, insulin, and potassium, which was thought could be a beneficial treatment immediately following a heart attack, may increase the risk of heart failure and death in the first 3 days for patients with ST-segment elevation myocardial infarction, according to a study in the Nov. 28 issue of JAMA.
Similar news · Read more »
- Pain control after surgery reduces days of hospitalization
03-26-2007 · EurekAlert!
Effective postoperative pain control using continuous peripheral nerve block reduced hospitalization by nearly a day, University of Pittsburgh physicians reported today during the 81st Clinical and Scientific Congress of the International Anesthesia Research Society.Being able to decrease the time that patients spend in the hospital helps to reduce the patient’s exposure to the risk of hospital-acquired infection and associated complications, and also has an overall economic benefit, Dr. Chelly and his colleagues found.
Similar news · Read more »
- Long-term use of diabetes drug increases heart attack risk by more than 40 percent
09-11-2007 · EurekAlert!
An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues. There was no effect on death from cardiovascular causes.
Similar news · Read more »
- Eating whole-grain breakfast cereals may be associated with a lower risk of heart failure for men
10-22-2007 · EurekAlert!
Men who consume a higher amount of whole grain breakfast cereals may have a reduced risk of heart failure, according to a report in the Oct. 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Similar news · Read more »
- Glycemic control medication appears to have favorable effect regarding risk of cardiovascular events
09-11-2007 · EurekAlert!
A meta-analysis of previous research suggests that use of pioglitazone -- a glycemic control medication for patients with type 2 diabetes -- significantly reduces the risk of heart attack, stroke and death, but increases the risk for serious heart failure, according to an article in the Sept. 12 issue of JAMA.
Similar news · Read more »
- Heart failure medication provides some symptom relief
03-25-2007 · EurekAlert!
A medication used to treat heart failure, tolvaptan, appears to improve some symptoms and signs of heart failure during hospitalization, but does not reduce the risk of re-hospitalization or death, according to two articles in the March 28 issue of JAMA. The study is being released early to coincide with its presentation at the American College of Cardiology's annual conference.
Similar news · Read more »
